CollPlant Biotechnologies Ltd (CLGN) Free cash flow 2018–2025
CollPlant Biotechnologies Ltd (CLGN) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$9.4MFY2025 · since FY2018: -$2.0M → -$9.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.4M | +35.2% |
| FY2024 | -$14.6M | -292.1% |
| FY2023 | -$3.7M | +75.2% |
| FY2022 | -$15.0M | -1495.3% |
| FY2021 | $1.1M | +122.0% |
| FY2020 | -$4.9M | +32.1% |
| FY2019 | -$7.2M | -251.1% |
| FY2018 | -$2.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CLGN financial trends
CLGN RevenueCLGN Net incomeCLGN Net marginCLGN Gross profitCLGN Gross marginCLGN Operating incomeCLGN Operating marginCLGN Operating cash flowCLGN Capital expendituresCLGN Return on equityCLGN Stock buybacksCLGN Dividends paidCLGN Total assetsCLGN Total liabilitiesCLGN Shareholders’ equityCLGN overview →